Back to results
US 2024/0190822 A1Published application
Mek inhibitors and uses thereof
AssigneeIkena Oncology, Inc.
InventorsAlfredo C. CASTRO, Michael J. Burke, Thomas A. Wynn, Sabine K. Ruppel, Sergio L. Santillana Soto, Eric Haines, Lan Xu, Oksana Zavidij
Life of this patent
Estimating the term…
Abstract
The present disclosure provides MEK inhibitors, compositions thereof, and methods of using the same.
Claims21
-20. (canceled)
A method of treating cancer in a subject, comprising administering to the subject a therapeutically effective amount of a compound selected from:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.